Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative Ondansetron Orally Dissolving Film for PONV Prevention in Pulmonary Surgery
ChiCTR2500105051Phase 4Not yet recruiting
- Sponsor
- Peking University Cancer Hospital & Institute
- Start
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in postoperative nausea and vomiting (PONV) comparing Ondansetron orally dissolving film with Control: Placebo orally dissolving film (2 arms). Primary endpoint: Incidence of nausea and/or vomiting within 24 hours after surgery. Planned start Jun 2025; status: not yet recruiting.
02
Drugs
ondansetron
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on ChiCTR2500105051.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500105051.